KoBioLabs, Inc (KOSDAQ:348150)

South Korea · Delayed Price · Currency is KRW

4,925.00

-175.00 (-3.43%)

At close: Feb 20, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Health Functional Food Division	68.36B	33.14B	11.61B	2.89B	4.59B
Health Functional Food Division Growth	106.28%	185.54%	301.12%	-36.98%	696.42%
Total	68.36B	33.14B	11.61B	2.89B	4.59B
Total Growth	106.28%	185.54%	301.12%	-36.98%	696.42%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
South Korea	68.09B	32.57B	10.67B	2.67B	4.59B
South Korea Growth	109.04%	205.23%	299.97%	-41.89%	696.42%
Overseas	265.25M	564.22M	933.81M	225.20M	-
Overseas Growth	-52.99%	-39.58%	314.67%	-	-
Total	68.36B	33.14B	11.61B	2.89B	4.59B
Total Growth	106.28%	185.54%	301.12%	-36.98%	696.42%

Source: S&P Global Market Intelligence.